ADHD is not rare. Roughly 8% of children and adolescents worldwide have the condition, and in the United States, 11.3% of children ages 5 to 17 have received an ADHD diagnosis at some point. Among adults globally, between 2.6% and 6.8% meet criteria depending on how strictly the condition is defined. By any measure, ADHD is one of the most common neurodevelopmental conditions in the world, affecting hundreds of millions of people across every country and culture studied.
How Common ADHD Is in Children
A meta-analysis pooling data from studies around the world found that 8% of children and adolescents have ADHD, with estimates ranging from 6% to 10% depending on the population studied. In the U.S., the numbers run higher. CDC survey data from 2020 to 2022 found that 11.3% of American children ages 5 to 17 had ever been diagnosed with ADHD. That translates to roughly 1 in 9 kids.
These rates have climbed steadily. U.S. national surveys show prevalence rising from 6.1% in 1997 to 10.2% in 2016. Several factors explain the increase: broader diagnostic criteria, greater awareness among parents and doctors, and improved access to care for groups that were previously overlooked. The condition itself may not be more common than it was decades ago, but more people are being identified.
Prevalence in Adults
Many people assume ADHD is a childhood condition that fades with age, but a large share of cases persist. A 2020 global analysis estimated that 2.58% of adults have persistent ADHD, meaning they still meet full diagnostic criteria from childhood. A broader measure, “symptomatic” adult ADHD, captures people who retain significant symptoms even if they no longer check every diagnostic box. That rate is 6.76%, translating to roughly 366 million adults worldwide.
Age matters. Among adults 18 to 24, about 5% meet criteria for persistent ADHD and 9% for the symptomatic form. By age 60 and older, those numbers drop to under 1% and about 4.5%, respectively. Whether this reflects genuine improvement over a lifetime or simply a generation that was far less likely to be evaluated remains an open question.
The Gender Gap in Diagnosis
Boys are diagnosed with ADHD at roughly twice the rate of girls. CDC data puts the childhood rate at 14.5% for boys and 8.0% for girls in the U.S. Research across age groups finds a consistent male-to-female diagnosis ratio of about 2:1, though older estimates placed it as high as 4:1.
That gap likely reflects diagnostic bias as much as biology. Girls with ADHD tend to present with the inattentive form, which looks like daydreaming and disorganization rather than the disruptive, hyperactive behavior that prompts referrals in boys. Because inattentive symptoms are easier to miss, many girls aren’t identified until adolescence or adulthood, if at all. This means the true rate of ADHD in women is almost certainly higher than current numbers suggest.
Racial Disparities in Who Gets Diagnosed
ADHD exists across every racial and ethnic group, but diagnosis rates are uneven. Black females are the demographic least likely to receive an ADHD diagnosis. A large-scale analysis found that the average age of diagnosis was more than eight years older for White patients than for Black patients, with far fewer Black adults receiving a diagnosis at all. Black and Hispanic children are also more likely to receive a diagnosis of oppositional defiant disorder or conduct disorder instead of ADHD, even when their behavior could be better explained by the underlying attention condition.
Researchers point to implicit bias among healthcare providers as a contributing factor. When clinicians interpret the same disruptive behaviors as defiance in one child and ADHD in another, the result is that minority populations get fewer referrals for evaluation, less access to treatment, and more punitive responses in school settings.
The Three Presentations and Which Is Most Common
ADHD comes in three recognized presentations: predominantly inattentive, predominantly hyperactive-impulsive, and combined. The inattentive form is by far the most common, accounting for about 45% of elementary school children with ADHD and as much as 75% of adolescents with the condition. It is also the most common presentation in adults. Because the inattentive form lacks the visible restlessness people associate with ADHD, it often goes unrecognized for years.
The combined presentation, where someone has significant symptoms of both inattention and hyperactivity, is the second most studied type and the one most people picture when they hear “ADHD.” The purely hyperactive-impulsive form is the least common and is seen most often in very young children.
Why Rates Vary So Much by Country
Published ADHD rates range from as low as 2.4% in some populations to nearly 20% in others, which might suggest the condition is far more common in certain countries. But that variation is mostly an artifact of how different health systems define and identify ADHD, not a reflection of real differences in behavior.
Studies in the 1970s reported a 20-fold difference in childhood hyperactivity between North America and England. Closer analysis showed that British and American children behaved similarly; the gap came down to British clinicians using a much narrower definition. When researchers apply the same diagnostic criteria across countries, the prevalence numbers converge. The overall conclusion from cross-national research is that ADHD occurs at broadly similar rates everywhere, with local differences driven by culture, awareness, and diagnostic practice.
How Changing Definitions Affect the Numbers
The diagnostic criteria for ADHD have been revised several times, and each revision has shifted who qualifies. The most recent update raised the age-of-onset cutoff from 7 to 12, meaning that someone whose symptoms became noticeable at age 10 can now receive a diagnosis when they previously could not. The threshold for adults was also lowered from six symptoms in a given category to five. And autism is no longer treated as a condition that rules out ADHD, so people with both can now be diagnosed with both.
Perhaps the most consequential change was to the definition of impairment. Previously, symptoms had to cause “clinically significant” problems. Now, they only need to “reduce the quality” of social, academic, or work functioning. That broader language captures more people whose ADHD is real but whose struggles might not have cleared the older, stricter bar. The net effect of all these changes is that more people qualify for a diagnosis today, which contributes to rising prevalence numbers without necessarily meaning more people actually have the condition.
The Economic Scale of ADHD
The sheer number of people affected gives ADHD a substantial economic footprint. Estimated annual costs in the U.S. range from $143 billion to $266 billion. Adults account for the majority of that burden, mostly through lost productivity and lower lifetime earnings, which alone represent $87 billion to $138 billion per year. For children, the biggest costs are healthcare and special education services. Family members absorb an additional $33 billion to $43 billion annually in indirect costs, including reduced work hours, caregiving time, and their own mental health needs.
These figures reinforce that ADHD is not a niche condition. It is a widespread part of the population’s health profile, comparable in prevalence to asthma in children and more common than many conditions that receive greater public attention.